Health/Diagnostics - Laboratory News

Breast cancer remains the most studied disease according to recent global analysis of thousands of clinical trials.

Cell Biology, Health, Health & Safety, Health/Diagnostics, Medical Diagnostics, Medical/Health, Oncology, Pharmaceutical, Policy, Virology

.tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="5a8e01ead47ba4735c34df81934fa0d4"] { padding: 0px;border: 1px solid rgba( 112, 112, 112, 1 ); } .tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="a361268826fdb4abfbd23cb7c98c86ee"] { padding: 15px; } .tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:var(--tb-button-icon-weight, normal) !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em} .tb-button[data-toolset-blocks-button="d15336fb035b26d1c608e0518041f8eb"] .tb-button__link { font-size: 15px;line-height: 15px; } .tb-button[data-toolset-blocks-button="d15336fb035b26d1c608e0518041f8eb"] .tb-button__icon { font-family: dashicons; } .tb-field[data-toolset-blocks-field="a38c87064193acb3d4e118731444f3e8"] { font-size: 14px;line-height: 1.5em; }  .tb-field[data-toolset-blocks-field="a38c87064193acb3d4e118731444f3e8"] a { line-height: 1.5em; } .tb-field[data-toolset-blocks-field="d090efcce1a772f31f59c379c494bcc5"] { font-size: 14px;font-weight: bold;line-height: 1.5em; }  .tb-field[data-toolset-blocks-field="d090efcce1a772f31f59c379c494bcc5"] a { line-height: 1.5em; }  .tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:var(--tb-button-icon-weight, normal) !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em} .tb-button[data-toolset-blocks-button="2d4b7ad616b6b86dd5f5d7d0b0edfbdc"] .tb-button__link { background-color: rgba( 207, 46, 46, 1 );font-size: 14px; } .tb-button[data-toolset-blocks-button="2d4b7ad616b6b86dd5f5d7d0b0edfbdc"] .tb-button__icon { font-family: dashicons; }  .tb-image{position:relative;transition:transform 0.25s ease}.wp-block-image .tb-image.aligncenter{margin-left:auto;margin-right:auto}.tb-image img{max-width:100%;height:auto;width:auto;transition:transform 0.25s ease}.tb-image .tb-image-caption-fit-to-image{display:table}.tb-image .tb-image-caption-fit-to-image .tb-image-caption{display:table-caption;caption-side:bottom} .wp-block-image.tb-image[data-toolset-blocks-image="3fa70a170f072ed1124efa9e636b87c6"] { max-width: 100%; }  @media only screen and (max-width: 781px) { .tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:var(--tb-button-icon-weight, normal) !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em}   .tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:var(--tb-button-icon-weight, normal) !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em} .tb-image{position:relative;transition:transform 0.25s ease}.wp-block-image .tb-image.aligncenter{margin-left:auto;margin-right:auto}.tb-image img{max-width:100%;height:auto;width:auto;transition:transform 0.25s ease}.tb-image .tb-image-caption-fit-to-image{display:table}.tb-image .tb-image-caption-fit-to-image .tb-image-caption{display:table-caption;caption-side:bottom}  } @media only screen and (max-width: 599px) { .tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:var(--tb-button-icon-weight, normal) !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em}   .tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:var(--tb-button-icon-weight, normal) !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em} .tb-image{position:relative;transition:transform 0.25s ease}.wp-block-image .tb-image.aligncenter{margin-left:auto;margin-right:auto}.tb-image img{max-width:100%;height:auto;width:auto;transition:transform 0.25s ease}.tb-image .tb-image-caption-fit-to-image{display:table}.tb-image .tb-image-caption-fit-to-image .tb-image-caption{display:table-caption;caption-side:bottom}  } 

Chemical sector welcomes REACH deadline consultation results

January 8, 2023

Chemical sector businesses and organisations have overwhelmingly backed extension of transitional registration deadlines for the new post-Brexit UK REACH regime, in response to a Whitehall consultation process.

Chemistry, Drug Discovery, Drugs & Pharmaceuticals, Health, Health/Diagnostics, Medical Diagnostics, Medical/Health, Pharma, Pharmaceutical, Pharmacology, Policy

Northern Ireland launches joined up diagnostics programme

December 11, 2022

Northern Ireland’s Health and Social Care service will combine millions of digital patient images into a single system that will enable it to manage approximately 2 million examinations annually.

Bioinformatics, Haematology, Health, Health & Safety, Health/Diagnostics, Immunology, Life Sciences, Medical Diagnostics, Medical/Health, Oncology, Physiology, Policy, Virology

Discovery Park unveils scheme to grow job opportunities 100% in a decade

December 11, 2022

Discovery Park plans to double the number of jobs it provides to around 7,000 over the next decade.

Biological Sciences, Biotech, Biotechnology, Health, Health/Diagnostics, Life Sciences, Medical Diagnostics, Medical/Health

Imaging breakthrough may provide ASD diagnosis biomarker

November 27, 2022

Scientists at Yale University say they have identified a possible biomarker for autism spectrum disorder (ASD), based upon one of the condition’s common hallmarks.

Biology, Developmental Biology, Health, Health/Diagnostics, Medical Diagnostics, Medical/Health, Neuroscience, Policy

Start-up raises £0.5 million-plus towards hard tumour immunotherapy goal

November 27, 2022

Start-up Neobe Therapeutics has raised £520K towards financing its endeavours to reduce barriers to immunotherapy in cancer patients with solid tumours.

Biology, Biotech, Cell Biology, Drug Discovery, Health/Diagnostics, Immunology, Life Sciences, Medical Diagnostics, Medical/Health, Pharmaceutical, Policy

Birmingham Uni institute’s Arlt to be new MRC London Institute Director

November 27, 2022

Award-winning clinical endocrinologist Professor Wiebke Arlt will be the new Director of the Medical Research Council London Institute of Medical Sciences from 1 January.

Biological Sciences, Biology, Biotech, Cell Biology, Genetics, Health, Health/Diagnostics, Immunology, Life Sciences, Medical Diagnostics, Medical/Health, Pharmaceutical, Physiology, Proteomics & Genomics

Data explosion threatens Catch 22 for pathogen research

November 20, 2022

Science’s efforts to tackle the challenge of antimicrobial resistance (AMR) is being hampered by the massive increase in the very information designed to help them in their efforts, warns a...

Biological Sciences, Biology, Biotech, Cell Biology, Drugs & Pharmaceuticals, Health, Health/Diagnostics, Medical/Health, Pharma, Pharmaceutical, Pharmacology, Physiology, Policy, Virology

Kent Uni lab aims to tackle footballer cardiac threat

November 20, 2022

The University of Kent claims it has achieved a first for UK labs by directly imaging at photomicrographic level how muscle activity is controlled.

Biological Sciences, Biology, Health & Safety, Health/Diagnostics, Medical Diagnostics, Medical/Health, Physiology

Heriot-Watt joint initiative to market medical design

November 14, 2022